{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,4,3]],"date-time":"2025-04-03T13:23:32Z","timestamp":1743686612311},"reference-count":12,"publisher":"Oxford University Press (OUP)","issue":"1","license":[{"start":{"date-parts":[[2024,5,7]],"date-time":"2024-05-07T00:00:00Z","timestamp":1715040000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/pages\/standard-publication-reuse-rights"}],"funder":[{"name":"60 Degrees Pharmaceuticals"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2024,7,25]]},"DOI":"10.1093\/infdis\/jiae193","type":"journal-article","created":{"date-parts":[[2024,5,7]],"date-time":"2024-05-07T13:03:01Z","timestamp":1715086981000},"page":"271-272","source":"Crossref","is-referenced-by-count":1,"title":["A Planned Trial to Evaluate the Safety and Efficacy of Tafenoquine + Atovaquone\/Azithromycin in Hospitalized Patients With Babesiosis"],"prefix":"10.1093","volume":"230","author":[{"given":"Geoffrey S","family":"Dow","sequence":"first","affiliation":[{"name":"60 Degrees Pharmaceuticals, Inc , Washington DC , USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bryan","family":"Smith","sequence":"additional","affiliation":[{"name":"60 Degrees Pharmaceuticals, Inc , Washington DC , USA"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"286","published-online":{"date-parts":[[2024,5,7]]},"reference":[{"key":"2024072520125729900_jiae193-B1","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1093\/infdis\/jiad315","article-title":"Tafenoquine-atovaquone combination achieves radical cure and confers sterile immunity in experimental models of human babesiosis","volume":"229","author":"Vydyam","year":"2024","journal-title":"J Infect Dis"},{"key":"2024072520125729900_jiae193-B2","doi-asserted-by":"crossref","first-page":"1599","DOI":"10.1093\/infdis\/jiae083","article-title":"Tafenoquine-based combination therapies: a step toward babesiosis elimination","volume":"229","author":"Liu","year":"2024","journal-title":"J Infect Dis"},{"key":"2024072520125729900_jiae193-B3"},{"key":"2024072520125729900_jiae193-B4","doi-asserted-by":"crossref","first-page":"1454","DOI":"10.1056\/NEJM200011163432004","article-title":"Atovaquone and azithromycin for the treatment of babesiosis","volume":"16","author":"Krause","year":"2000","journal-title":"N Engl J Med"},{"key":"2024072520125729900_jiae193-B5","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1111\/trf.16718","article-title":"Babesia blood testing: the first-year experience","volume":"62","author":"Tonnetti","year":"2022","journal-title":"Tranfusion"},{"key":"2024072520125729900_jiae193-B6","doi-asserted-by":"crossref","first-page":"e0024021","DOI":"10.1128\/AAC.00204-21","article-title":"Tafenoquine is a promising drug candidate for the treatment of babesiosis","volume":"65","author":"Liu","year":"2021","journal-title":"Antimicrob Agents Chemother"},{"key":"2024072520125729900_jiae193-B7","doi-asserted-by":"crossref","first-page":"480","DOI":"10.1093\/cid\/ciy939","article-title":"Blood schizonticidal activity of tafenoquine when administered as chemoprophylaxis to healthy, non-immune participants followed by blood stage Plasmodium falciparum challenge: a randomized, placebo-controlled, double-blind phase 1b study","volume":"69","author":"McCarthy","year":"2019","journal-title":"Clin Infect Dis"},{"key":"2024072520125729900_jiae193-B8","doi-asserted-by":"crossref","first-page":"1919","DOI":"10.1093\/cid\/ciad075","article-title":"Characterizing the blood-stage antimalarial activity of tafenoquine in healthy volunteers experimentally infected with Plasmodium falciparum","volume":"76","author":"Barber","year":"2023","journal-title":"Clin Infect Dis"},{"key":"2024072520125729900_jiae193-B9","doi-asserted-by":"crossref","first-page":"588","DOI":"10.1186\/s12936-016-1632-8","article-title":"Cytochrome P450 2D-mediated metabolism is not necessary for tafenoquine and primaquine to eradicate the erythrocytic stages of Plasmodium berghei","volume":"15","author":"Milner","year":"2016","journal-title":"Malar J"},{"key":"2024072520125729900_jiae193-B10","doi-asserted-by":"crossref","first-page":"442","DOI":"10.1093\/infdis\/jiz119","article-title":"Could the drug tafenoquine revolutionize treatment of Babesia microti infection?","volume":"220","author":"Mordue","year":"2019","journal-title":"J Infect Dis"},{"issue":"Suppl 1","key":"2024072520125729900_jiae193-B11","doi-asserted-by":"crossref","first-page":"617","DOI":"10.1093\/milmed\/usz304","article-title":"Army antimalarial drug development\u2014an advanced development case study for tafenoquine","volume":"185","author":"Zottig","year":"2020","journal-title":"Mil Med"},{"key":"2024072520125729900_jiae193-B12","doi-asserted-by":"crossref","first-page":"102211","DOI":"10.1016\/j.tmaid.2021.102211","article-title":"Long-term safety of the tafenoquine antimalarial chemoprophylaxis regimen\u2014a 12-month, randomized, double-blind, placebo-controlled trial","volume":"45","author":"Novitt-Moreno","year":"2022","journal-title":"Travel Med Infect Dis"}],"container-title":["The Journal of Infectious Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/jid\/advance-article-pdf\/doi\/10.1093\/infdis\/jiae193\/57727410\/jiae193.pdf","content-type":"application\/pdf","content-version":"am","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/jid\/article-pdf\/230\/1\/271\/58649562\/jiae193.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/jid\/article-pdf\/230\/1\/271\/58649562\/jiae193.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,7,25]],"date-time":"2024-07-25T20:16:50Z","timestamp":1721938610000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/jid\/article\/230\/1\/271\/7660017"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,5,7]]},"references-count":12,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2024,5,7]]},"published-print":{"date-parts":[[2024,7,25]]}},"URL":"https:\/\/doi.org\/10.1093\/infdis\/jiae193","relation":{},"ISSN":["0022-1899","1537-6613"],"issn-type":[{"value":"0022-1899","type":"print"},{"value":"1537-6613","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2024,7,15]]},"published":{"date-parts":[[2024,5,7]]}}}